A new study confirms that semaglutide, commonly used to treat diabetes and weight loss, may also reduce alcohol consumption in individuals with symptoms of alcohol use disorder. The phase 2 clinical trial found a significant 30% reduction in alcohol consumption per drinking day among those taking the medication compared to a 2% reduction in the placebo group. This could be life-changing for nearly 30 million people in the US affected by alcohol use disorder.
Source: https://www.sciencealert.com/ozempic-reduces-desire-to-binge-alcohol-suggests-amazing-new-study